-+ 0.00%
-+ 0.00%
-+ 0.00%

RBC Capital Maintains Outperform on Globus Medical, Lowers Price Target to $85

Benzinga·10/01/2026 13:05:59
Listen to the news
RBC Capital analyst Kendall Au maintains Globus Medical (NYSE:GMED) with a Outperform and lowers the price target from $115 to $85.